FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.22-SNAPSHOT  |  FHIR Version n/a  User: [n/a]

83968007: Clemastine fumarate (substance)

Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2002. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
139242015 Clemastine fumarate en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
139243013 Meclastine fumarate en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
139244019 Mecloprodin fumarate en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
825712013 Clemastine fumarate (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
801301000172117 fumarate de clémastine fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Clemastine fumarate Is a Product containing clemastine (medicinal product) false Inferred relationship Some
Clemastine fumarate Is a Clemastine (substance) false Inferred relationship Some
Clemastine fumarate This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context. Histamine receptor antagonist (disposition) false Inferred relationship Some
Clemastine fumarate This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. Clemastine (substance) true Inferred relationship Some
Clemastine fumarate Is a Ethanolamine derivative antihistamine true Inferred relationship Some
Clemastine fumarate Is a Histamine H1 receptor antagonist true Inferred relationship Some
Clemastine fumarate Is a A grouper concept for substances that are used in medicinal products for medical treatment, and also psychoactive substances that have few or no legitimate medical uses or that are not legally available to the person using them. true Inferred relationship Some
Clemastine fumarate This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context. Histamine H1 receptor antagonist (disposition) true Inferred relationship Some
Inbound Relationships Type Active Source Characteristic Refinability Group
Clemastine fumarate 0.67mg/5mL syrup The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Clemastine fumarate Inferred relationship Some
Clemastine fumarate 2.68 mg oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Clemastine fumarate Inferred relationship Some
Product containing clemastine fumarate and paracetamol and phenylpropanolamine The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Clemastine fumarate Inferred relationship Some
Product containing precisely clemastine fumarate 335 microgram and paracetamol 500 milligram and phenylpropanolamine 30 milligram/1 each conventional release oral tablet (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Clemastine fumarate Inferred relationship Some
Clemastine fumarate 2.68 mg oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Clemastine fumarate Inferred relationship Some 1
Clemastine fumarate 2.68 mg oral tablet This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Clemastine fumarate Inferred relationship Some 1
Product containing precisely clemastine fumarate 335 microgram and paracetamol 500 milligram and phenylpropanolamine 30 milligram/1 each conventional release oral tablet (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Clemastine fumarate Inferred relationship Some 3
Product containing precisely clemastine fumarate 335 microgram and paracetamol 500 milligram and phenylpropanolamine 30 milligram/1 each conventional release oral tablet (clinical drug) This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Clemastine fumarate Inferred relationship Some 3
Product containing precisely clemastine fumarate 335 microgram and paracetamol 500 milligram and phenylpropanolamine 30 milligram/1 each conventional release oral tablet (clinical drug) This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. False Clemastine fumarate Inferred relationship Some 1
Product containing precisely clemastine fumarate 335 microgram and paracetamol 500 milligram and phenylpropanolamine 30 milligram/1 each conventional release oral tablet (clinical drug) The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). False Clemastine fumarate Inferred relationship Some 1
Clemastine fumarate 2.68 mg oral tablet The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Clemastine fumarate Inferred relationship Some 1
Clemastine fumarate hydrochloride This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. True Clemastine fumarate Inferred relationship Some
Product containing precisely clemastine fumarate 134 microgram/1 milliliter conventional release oral solution (clinical drug) The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Clemastine fumarate Inferred relationship Some 1
Product containing precisely clemastine fumarate 134 microgram/1 milliliter conventional release oral solution (clinical drug) This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Clemastine fumarate Inferred relationship Some 1
Clemastine fumarate 670 microgram and phenylpropanolamine 25 mg oral tablet This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Clemastine fumarate Inferred relationship Some 2
Clemastine fumarate 670 microgram and phenylpropanolamine 25 mg oral tablet The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Clemastine fumarate Inferred relationship Some 2
Clemastine fumarate 1.34 mg oral tablet The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Clemastine fumarate Inferred relationship Some 1
Clemastine fumarate 1.34 mg oral tablet This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Clemastine fumarate Inferred relationship Some 1
Product containing precisely clemastine fumarate 335 microgram and paracetamol 500 milligram and phenylpropanolamine 30 milligram/1 each conventional release oral tablet (clinical drug) The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Clemastine fumarate Inferred relationship Some 3

This concept is not in any reference sets

Back to Start